Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001780649-25-000002

CEO and Chairman sold 89,265 shares at an average $14.73 ($1,315,180)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROBINS CHAD M · CEO and Chairman

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-10 Sale : show line 1 in the form 10b5-1 −86,161 $14.73 $1,269,152 2,873,088 D
2025-11-11 Sale : show line 2 in the form 10b5-1 −1,237 $14.57 $18,023 2,871,851 D
2025-11-12 Sale : show line 3 in the form 10b5-1 −1,867 $15.00 $28,005 2,869,975 D
Open-market sales · 89,265 sh · avg $14.73 · $1,315,180
Loading xslF345X05/primary_doc.xml…